Mechanism of action and receptor profile
The core pharmacological activity of the drug lies in its dual interaction with the receptor apparatus of the central nervous system.
As an agonist, it stimulates $\kappa$- (kappa) and $\delta$- (delta) opioid receptors. This mechanism is responsible for the development of analgesia. However, it is important to note that its analgesic activity is significantly lower than that of classical Morphinum. At the same time, the drug causes less respiratory depression.
Simultaneously, the agent acts as a antagonist of $\mu$ (mu) receptors. Blocking these structures prevents the drug from causing euphoria, and the overall risk of drug dependence is significantly lower. However, stimulation of kappa receptors carries risks and can provoke dysphoria.
Interaction with pure agonists
When co-administered with full opioid agonists (e.g., morphine), the drug acts as a competitive antagonist. It is capable of physically displacing pure agonists from receptor binding.
This poses a major clinical hazard for individuals with established drug dependence: administering the drug immediately precipitates acute withdrawal syndrome.
Pharmacokinetics
The drug is well absorbed via all routes of administration. It can be administered enterally (orally) or parenterally (subcutaneously, intramuscularly, intravenously).
The onset of effect strictly depends on the route of delivery:
- Intravenously: onset of action is observed in 2–3 minutes, with peak effect reached in 15–30 minutes.
- Intramuscularly and orally: effect begins in 15–30 minutes, peaking at 30–60 minutes.
The total duration of the therapeutic effect of the drug is up to 3 hours.
Effects on the cardiovascular system
The drug exerts a pronounced stimulating effect on hemodynamics. It increases pressure in the pulmonary artery system, increases preload, and raises total cardiac workload. In addition, administration of the agent is accompanied by tachycardia and elevated blood pressure.
Due to the risk of critical myocardial overload, the drug is not recommended for use in patients with myocardial infarction.
Side effects and contraindications
Specific central nervous system side effects include the development of dysphoria and hallucinations.
Absolute contraindications for prescribing include:
- Bronchial asthma;
- Traumatic brain injury (TBI);
- Epilepsy;
- Cholelithiasis and urolithiasis;
- Severe hepatic and renal impairment.
There are also strict restrictions on use during pregnancy, lactation, and in children under 1 year of age.
Briefly: answers to topical questions
What doses of pentazocine are prescribed to adults for acute pain relief?
Available materials do not describe dosages for acute pain relief, but they do present dosing regimens for dental procedures.
Preoperative dosages:
- Orally — 50–75 mg 40–60 minutes before the procedure.
- Intravenously — 30–60 mg combined with diazepam 5 minutes before the start.
Pentazocine is also used as one of the analgesics during ataralgesia in combination with sedative psychotropic drugs.
To remember the receptor profile, use the mnemonic: "KAPPA DELTA provide analgesia, while the MU-sical is cancelled". This means the drug stimulates KAPPA and DELTA receptors (pain relief), but blocks MU receptors (no euphoria).
Class and exam questions
Why is pentazocine contraindicated in myocardial infarction?
The drug increases preload, elevates pulmonary artery pressure, and causes tachycardia. This forces the heart to work harder, which is critically dangerous in acute myocardial ischemia.
What happens if pentazocine is administered to a person with opioid dependence?
It will act as a competitive antagonist: displacing pure opioids from receptor binding, which will immediately provoke a severe acute withdrawal syndrome (cold turkey).
Does this drug cause euphoria?
No, because it is a mu receptor antagonist. On the contrary, due to kappa receptor stimulation, the patient may develop dysphoria and hallucinations.
What else to study on this topic
- Molecular mechanism of competitive antagonism at opioid receptors
- Causes of dysphoria upon kappa receptor stimulation
- Comparison of hemodynamic effects of pentazocine and morphine
- Pharmacodynamics of benzomorphan derivatives
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Pentazocine" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the "Analgesics" section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.